Home » Business » Pfizer Makes Final Cash and Shares Offer to AstraZeneca Shareholders

Pfizer Makes Final Cash and Shares Offer to AstraZeneca Shareholders

Pfizer have made a final offer to shareholders of AstraZeneca in a move which will proclude any further offers. Under the terms of the final proposal AstraZeneca shareholders would receive, for each AstraZeneca share, 1.747 shares in the combined entity and 2,476 pence in cash, representing an indicative value of £55.00 ($92.53) per share.

Under the final proposal, Pfizer and AstraZeneca shareholders would own approximately 74% and 26%, respectively, of the combined company. Pfizer’s proposal will expire at 5pm London time on 26th May 2014.

 

About Business Desk

Business Desk
Editors and staff from the Business Desk at The Global Herald.

Check Also

Fiat Chrysler to invest $1 billion in two US plants

US President-elect Donald Trump has the auto industry in an uproar, suggesting a possible 35% …

Leave a Reply

Your email address will not be published. Required fields are marked *